PIN6 CLINICAL BENEFITS AND COST SAVINGS FROM IMPLEMENTING A SIMPLIFIED STRATEGY FOR GLECAPREVIR/PIBRENTASVIR (G/P) 8-WEEK TREATMENT IN NON-CIRRHOTIC NAÃVE PATIENTS WITH HEPATITIS C. THE JUST SIMPLE STUDY (REAL CLINICAL PRACTICE IN SPAIN).
May 1, 2020, 00:00
10.1016/j.jval.2020.04.482
https://www.valueinhealthjournal.com/article/S1098-3015(20)30670-7/fulltext
Title :
PIN6 CLINICAL BENEFITS AND COST SAVINGS FROM IMPLEMENTING A SIMPLIFIED STRATEGY FOR GLECAPREVIR/PIBRENTASVIR (G/P) 8-WEEK TREATMENT IN NON-CIRRHOTIC NAÃVE PATIENTS WITH HEPATITIS C. THE JUST SIMPLE STUDY (REAL CLINICAL PRACTICE IN SPAIN).
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)30670-7&doi=10.1016/j.jval.2020.04.482
First page :
Section Title :
Open access? :
No
Section Order :
10356